Slideshow
Author(s):
Results of a new study highlight the importance of intensive treatment of all comorbidities associated with adult growth hormone deficiency.
Semaglutide 7.2 mg Displays 20.7% Weight Loss in Phase 3b STEP UP Trial
Diabetes Dialogue: ADA’s 2025 Standards of Care in Diabetes Technology
Genetic Determinants of LDL-C Inversely Linked to Type 2 Diabetes Risk
Diabetes Dialogue: The Evolving Role of Registered Dietitian Nutritionists in Obesity
FMT Shows Promise for Type 1 Diabetes, Gastroenteropathy Treatment in Pilot Trial
Atumelnant Reduces Key CAH Biomarkers, Hits Primary Phase 2 Endpoint